Cost-Effectiveness Analysis of Triple Therapeutic Schemes of Prazoles for Hp Infection
- VernacularTitle:3种拉唑类三联疗法治疗幽门螺杆菌感染的成本-效果分析
- Author:
Bangsheng ZHANG
;
Jianning WANG
- Publication Type:Journal Article
- Keywords:
Omeprazole;
Rabeprazole;
Pantoprazole;
Hp infection;
Cost-effectiveness analysis
- From:
China Pharmacy
2005;0(17):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To evaluate the economic effectiveness of different pharmacotherapentic schemes of Prazoles for helicobacteria pylori (Hp) infection. METHODS: 102 patietns with peptic ulcer were randomly assigned to receive Omeprazole +amoxicillin + Colloidal bismmth pectin (Group A), Rabeprazole + Amoxicillin + Colloidal bismmth pectin (Group B) or Rebeprazole + amoxicillin + Colloidal bismmth pectin (Group C). The cost-effectiveness analysis was conducted on the three schemes. RESULTS: The cost-effectiveness ratios of groups A, B and C on Hp clearance rates were 1 027.31, 976.79 and 967.40, respectively, and on peptic ulcer healing rates were 921.05, 915.77 and 936.16, respectively. CONCLUSION: Scheme B is the best one for Hp infection.
